홈 > 시장보고서 > 의약품 > 게놈 창약

시장보고서

상품코드

1363118

계산생물학 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Computational Biology Market Size, Share & Trends Analysis Report By Service (Database, Infrastructure & Hardware, Software Platform), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

발행일: 2023년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

계산생물학 시장의 성장과 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 계산생물학 시장 규모는 2030년까지 132억 5,000 달러에 달하고, CAGR은 13.17%에 달할 것으로 예측됩니다.

암 연구 분야의 R&D 투자 증가, 맞춤형 의약품에 대한 수요 증가, 신약 개발 연구 활성화가 시장 성장에 기여할 것으로 예상됩니다. 또한, 생명공학 산업의 발전과 인공지능 기술의 채택이 증가하면서 예측 기간 동안 시장 성장을 더욱 촉진할 것으로 보입니다.

유전자 분석에서 첨단 기술 채택이 확대되면서 계산생물학 시장의 성장을 촉진하고 있습니다. 예를 들어, 2023년 1월 Qiagen Digital Insights(QDI)는 초고속 차세대 시퀀싱(NGS) 분석을 위해 설계된 향상된 제품을 발표했습니다. 이 혁신적인 솔루션은 1달러의 클라우드 컴퓨팅 비용으로 25분 이내에 전체 게놈을 처리할 수 있습니다. 이를 통해 연구자들은 전체 게놈 시퀀싱(WGS), 전체 엑솜 시퀀싱(WES), 대규모 패널 시퀀싱 등 다양한 시퀀싱 접근법에서 얻은 데이터를 효율적으로 분석 및 해석할 수 있을 것으로 예상됩니다. 따라서 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

그리고 2023년 9월 크립토폴리탄이 보도한 기사에 따르면, 포항공과대학교(POSTECH) 과학자들은 EBioMedicine 저널을 통해 기계학습을 통해 신약이 임상시험 전에도 승인될 가능성을 추정할 수 있다는 연구 결과를 공유했습니다. 이는 임상시험 중 약물의 실패율을 이해하는 데 도움이 될 것으로 기대됩니다. 이러한 기술 발전의 증가는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

그러나 생물학적 시스템의 복잡성과 이 분야의 숙련된 전문가 부족이 시장 성장을 저해할 것으로 예상됩니다. 생물학적 시스템은 매우 복잡하기 때문에 그 행동을 정확하게 모델링하기 어렵고, 숙련되고 훈련된 전문가의 존재가 필요합니다. 많은 생물학적 과정은 복잡한 네트워크와 상호 작용을 포함하기 때문에 분석의 복잡성을 더욱 증가시키고, 계산에 의한 예측의 신뢰성을 떨어뜨리는 경우도 있습니다.

계산생물학 시장 보고서 하이라이트

서비스별로는 소프트웨어 및 플랫폼 분야가 2022년 39.06%의 점유율로 시장을 장악하고 예측 기간 동안 가장 빠른 CAGR로 성장할 것으로 예상됩니다. 그 배경에는 신약 및 약물 개발의 증가와 개인 맞춤형 의약품에 대한 수요 증가가 있습니다.
용도별로는 임상시험 분야가 2022년 26.84%의 점유율로 시장을 장악했습니다. 이는 주로 이 분야의 R&D 이니셔티브가 증가했기 때문입니다.
최종 용도별로는 2022년 산업용 부문이 62.10%로 가장 큰 시장 점유율을 차지했습니다. 이는 신약 개발, 표적 식별, 가상 스크리닝, 약동학 모델링과 같은 다른 용도의 연구 활동이 증가했기 때문입니다.
2022년에는 북미가 48.93%의 점유율로 시장을 지배했는데, 이는 주요 시장 기업의 존재와 탄탄한 의료 인프라에 기인합니다. 이는 예측 기간 동안 이 지역의 계산생물학 시장을 견인할 것으로 예상됩니다.

The global computational biology market size is expected to reach a value of USD 13.25 billion by 2030, according to a new report by Grand View Research, Inc.., exhibiting a CAGR of 13.17%. The growing investments in research & development within the fields of cancer research, increasing demand for personalized medicines, and rising drug discovery & development are anticipated to contribute to the growth of the market. Moreover, the increasing advancements in the biotechnology industry and the adoption of artificial intelligence technology will further drive the market growth over the forecast period.

The growing adoption of advanced technology in gene analysis is propelling the growth of the market for computational biology. For instance, in January 2023, Qiagen Digital Insights (QDI) introduced an enhanced product designed for ultra-rapid next-generation sequencing (NGS) analysis. This innovative solution enables the processing of the entire genome within just 25 minutes, for USD 1 in cloud computing expenses. This is anticipated to empower researchers to efficiently analyze and interpret data from various sequencing approaches, including whole genome sequencing (WGS), whole exome sequencing (WES), and large panel sequencing. Hence, it is anticipated to impel market growth over the forecast period.

Furthermore, according to the article published by Cryptopolitan in September 2023, in a major advance development, scientists at Pohang University of Science and Technology (POSTECH) have shared their discoveries in the EBioMedicine journal, that they have used machine learning to estimate the chances of a new drug getting approved even before the clinical trials. This is expected to help in understanding the rate of drug failure at the time of clinical trials. Thus, the rising advancements in technology are anticipated to fuel the growth of the market over the forecast period.

However, the complexity of the biological systems and the lack of skilled professionals in the field are anticipated to hinder the growth of the market. Biological systems are incredibly complex, and accurately modeling their behavior can be challenging and requires the presence of skilled and trained professionals. Many biological processes involve complicated networks and interactions, which further add to the complexity of analysis and make computational predictions less reliable in some cases.

Computational Biology Market Report Highlights:

Based on service, the software & platform segment dominated the market with a share of 39.06% in 2022, and the same is anticipated to grow at the fastest CAGR over the forecast period. This can be attributed to the rising drug discovery & development and growing demand for personalized medicines
Based on application, the clinical trials segment dominated the market with a share of 26.84% in 2022. This was primarily due to an increase in the number of R&D initiatives in this field.
Based on end-use, the industrial segment held the largest market share of 62.10% in 2022. This can be attributed to the increasing research activities for drug discovery, target identification, virtual screening, and pharmacokinetic modeling, among other applications
In 2022, North America dominated the market with a share of 48.93%, owing to the presence of major market players, and robust healthcare infrastructure. These are anticipated to boost the market for computational biology in the region over the forecast period

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
- 1.2.1. Service Segment
- 1.2.2. Application Segment
- 1.2.3. End-use Segment
1.3. Research Assumptions
1.4. Information Procurement
- 1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- 1.9.3. Objective 3

Chapter 2. Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Variables, Trends, & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
- 3.3.1. Growing Adoption Of Bioinformatics Technology
- 3.3.2. Advancements In Genomic Research
- 3.3.3. Increasing Demand For Personalized Medicines
3.4. Market Restraint Analysis
- 3.4.1. Lack of Skilled Professional
- 3.4.2. Data Privacy And Security Concerns
3.5. Business Environment Analysis
- 3.5.1. PESTEL Analysis
- 3.5.2. Porter's Five Forces Analysis
- 3.5.3. COVID-19 Impact Analysis

Chapter 4. Service Business Analysis

4.1. Computational Biology Market: Service Movement Analysis
4.2. Databases
- 4.2.1. Databases Market, 2018 - 2030 (USD Million)
4.3. Infrastructure & Hardware
- 4.3.1. Infrastructure & Hardware, 2018 - 2030 (USD Million)
4.4. Software Platform
- 4.4.1. Software Platform Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

5.1. Computational Biology Market: Application Movement Analysis
5.2. Drug Discovery & Disease Modelling
- 5.2.1. Drug Discovery & Disease Modelling Market, 2018 - 2030 (USD Million)
- 5.2.2. Target Identification
  - 5.2.2.1. Target Identification Market, 2018 - 2030 (USD Million)
- 5.2.3. Target Validation
  - 5.2.3.1. Target Validation Market, 2018 - 2030 (USD Million)
- 5.2.4. Lead Discovery
  - 5.2.4.1. Lead Discovery Market, 2018 - 2030 (USD Million)
- 5.2.5. Lead Optimization
  - 5.2.5.1. Lead Optimization Market, 2018 - 2030 (USD Million)
5.3. Preclinical Drug Development
- 5.3.1. Preclinical Drug Development Market, 2018 - 2030 (USD Million)
- 5.3.2. Pharmacokinetics
  - 5.3.2.1. Pharmacokinetics Market, 2018 - 2030 (USD Million)
- 5.3.3. Pharmacodynamics
  - 5.3.3.1. Pharmacodynamics Market, 2018 - 2030 (USD Million)
5.4. Clinical Trials
- 5.4.1. Clinical Trials Market, 2018 - 2030 (USD Million)
- 5.4.2. Phase I
  - 5.4.2.1. Phase I Market, 2018 - 2030 (USD Million)
- 5.4.3. Phase II
  - 5.4.3.1. Phase II Market, 2018 - 2030 (USD Million)
- 5.4.4. Phase III
  - 5.4.4.1. Phase III Market, 2018 - 2030 (USD Million)
- 5.4.5. Phase IV
  - 5.4.5.1. Phase IV Market, 2018 - 2030 (USD Million)
5.5. Computational Genomics
- 5.5.1. Computational Genomics Market, 2018 - 2030 (USD Million)
5.6. Computational Proteomics
- 5.6.1. Computational Proteomics Market, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

6.1. Computational Biology Market: End-use Movement Analysis
6.2. Academic & Research
- 6.2.1. Academic & Research Market, 2018 - 2030 (USD Million)
6.3. Industrial
- 6.3.1. Industrial Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

7.1. Regional Market Snapshot
7.2. North America
- 7.2.1. North America Computational Biology Market, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.2.2.2. Key Country Dynamics
  - 7.2.2.3. Competitive Scenario
- 7.2.3. Canada
  - 7.2.3.1. Canada Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.2.3.2. Key Country Dynamics
  - 7.2.3.3. Competitive Scenario
7.3. Europe
- 7.3.1. Europe Computational Biology Market, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.2.2. Key Country Dynamics
  - 7.3.2.3. Competitive Scenario
- 7.3.3. Germany
  - 7.3.3.1. Germany Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.3.2. Key Country Dynamics
  - 7.3.3.3. Competitive Scenario
- 7.3.4. Spain
  - 7.3.4.1. Spain Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.4.2. Key Country Dynamics
  - 7.3.4.3. Competitive Scenario
- 7.3.5. France
  - 7.3.5.1. France Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.5.2. Key Country Dynamics
  - 7.3.5.3. Competitive Scenario
- 7.3.6. Italy
  - 7.3.6.1. Italy Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.6.2. Key Country Dynamics
  - 7.3.6.3. Competitive Scenario
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.7.2. Key Country Dynamics
  - 7.3.7.3. Competitive Scenario
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.8.2. Key Country Dynamics
  - 7.3.8.3. Competitive Scenario
- 7.3.9. Norway
  - 7.3.9.1. Norway Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.3.9.2. Key Country Dynamics
  - 7.3.9.3. Competitive Scenario
7.4. Asia Pacific
- 7.4.1. Asia-Pacific Computational Biology Market, 2018 - 2030 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Japan Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.4.2.2. Key Country Dynamics
  - 7.4.2.3. Competitive Scenario
- 7.4.3. China
  - 7.4.3.1. China Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.4.3.2. Key Country Dynamics
  - 7.4.3.3. Competitive Scenario
- 7.4.4. India
  - 7.4.4.1. India Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.4.4.2. Key Country Dynamics
  - 7.4.4.3. Competitive Scenario
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.4.5.2. Key Country Dynamics
  - 7.4.5.3. Competitive Scenario
- 7.4.6. Thailand
  - 7.4.6.1. Thailand Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.4.6.2. Key Country Dynamics
  - 7.4.6.3. Competitive Scenario
- 7.4.7. Australia
  - 7.4.7.1. Australia Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.4.7.2. Key Country Dynamics
  - 7.4.7.3. Competitive Scenario
7.5. Latin America
- 7.5.1. Latin America Computational Biology Market, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.5.2.2. Key Country Dynamics
  - 7.5.2.3. Competitive Scenario
- 7.5.3. Mexico
  - 7.5.3.1. Mexico Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.5.3.2. Key Country Dynamics
  - 7.5.3.3. Competitive Scenario
- 7.5.4. Argentina
  - 7.5.4.1. Argentina Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.5.4.2. Key Country Dynamics
  - 7.5.4.3. Competitive Scenario
7.6. MEA
- 7.6.1. MEA Computational Biology Market, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. South Africa Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.6.2.2. Key Country Dynamics
  - 7.6.2.3. Competitive Scenario
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Saudi Arabia Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.6.3.2. Key Country Dynamics
  - 7.6.3.3. Competitive Scenario
- 7.6.4. UAE
  - 7.6.4.1. UAE Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.6.4.2. Key Country Dynamics
  - 7.6.4.3. Competitive Scenario
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Computational Biology Market, 2018 - 2030 (USD Million)
  - 7.6.5.2. Key Country Dynamics
  - 7.6.5.3. Competitive Scenario

Chapter 8. Competitive Landscape

8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Share/Position Analysis, 2022
8.4. Company Profiles/Listing
- 8.4.1. DNAnexus, Inc.
  - 8.4.1.1. Company Overview
  - 8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Strategic Initiatives
- 8.4.2. Illumina, Inc.
  - 8.4.2.1. Company Overview
  - 8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Strategic Initiatives
- 8.4.3. Thermo Fisher Scientific, Inc.
  - 8.4.3.1. Company Overview
  - 8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Strategic Initiatives
- 8.4.4. Schrodinger, Inc.
  - 8.4.4.1. Company Overview
  - 8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Strategic Initiatives
- 8.4.5. Compugen
  - 8.4.5.1. Company Overview
  - 8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Strategic Initiatives
- 8.4.6. Aganitha AI Inc.
  - 8.4.6.1. Company Overview
  - 8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Strategic Initiatives
- 8.4.7. Genedata AG
  - 8.4.7.1. Company Overview
  - 8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Strategic Initiatives
- 8.4.8. QIAGEN
  - 8.4.8.1. Company Overview
  - 8.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Strategic Initiatives
- 8.4.9. SIMULATIONS PLUS
  - 8.4.9.1. Company Overview
  - 8.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Strategic Initiatives
- 8.4.10. Fios Genomics
  - 8.4.10.1. Company Overview
  - 8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Strategic Initiatives

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,950

￦ 8,609,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950

￦ 10,055,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950

￦ 12,949,000

※ 부가세 별도

계산생물학 시장 규모, 점유율, 동향 분석 보고서 : 서비스별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Computational Biology Market Size, Share & Trends Analysis Report By Service (Database, Infrastructure & Hardware, Software Platform), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

계산생물학 시장의 성장과 동향:

계산생물학 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 변수, 동향, 범위

제4장 서비스별 비지니스 분석

제5장 용도별 비지니스 분석

제6장 최종 용도별 비지니스 분석

제7장 지역별 비지니스 분석

제8장 경쟁 상황

Computational Biology Market Growth & Trends: